University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Bradley A. Stohr, MD, PhD

Bradley A. Stohr, MD, PhD

Assistant Professor, Department of Pathology, UCSF
Stuart Lindsay Endowed Professorship in Experimental Pathology III, UCSF

Cancer Center Program Memberships

Non-aligned

Education

Swarthmore College, Swarthmore, PA, BA, 1995, Biology
Duke University, Durham, NC, PhD, 2002, Microbiology
Duke University, Durham, NC, MD, 2003, Medicine
University of California, San Francisco, CA, Resident/Fellow, 2003-2006, Anatomic Pathology
University of California, San Francisco, CA, Postdoctoral Fellow, 2005-2008, Biochemistry


Professional Experience

  • 1993-1994
    Research Assistant, Jackson Laboratory. Advisor: Sandya Narayanswami, Ph.D.
  • 1995-1996
    Research Assistant, Department of Microbiology, University of California, Davis. Advisor: Satya Dandekar, Ph.D.
  • 1998-2002
    Graduate Student, Department of Microbiology, Duke University Advisor: Kenneth Kreuzer, Ph.D.
  • 2003-2006
    Resident/Fellow, Anatomic Pathology, University of California, San Francisco
  • 2005-2008
    Postdoctoral Fellow, Department of Biochemistry, University of California, San Francisco Advisor: Elizabeth Blackburn, Ph.D.
  • 2008-2010
    Clinical Instructor, Department of Pathology, University of California, San Francisco

Honors & Awards

  • 1995
    Phi Beta Kappa honor society
  • 1995
    Sigma Xi honor society
  • 1996-2003
    Medical Scientist Training Program Fellowship
  • 2005
    Ruth L. Kirschstein Postdoctoral Fellowship (declined)
  • 2005-2008
    American Cancer Society Postdoctoral Fellowship
  • 2010-present
    Mentored Clinical Scientist Development Award (K08)

Selected Publications

  1. Ravindranathan A, Diolaiti ME, Cimini BA, Stohr BA. In Situ Visualization of Telomere Length, Telomere Elongation, and TERT Expression in Single Cells. Curr Protoc Cell Biol. 2019 Dec; 85(1):e97.
    View on PubMed
  2. Fergus KB, Lee AW, Baradaran N, Cohen AJ, Stohr BA, Erickson BA, Mmonu NA, Breyer BN. Pathophysiology, Clinical Manifestations, and Treatment of Lichen Sclerosus: a systematic review. Urology. 2019 Oct 09.
    View on PubMed
  3. Sirohi D, Devine P, Grenert JP, van Ziffle J, Simko JP, Stohr BA. TP53 structural variants in metastatic prostatic carcinoma. PLoS One. 2019; 14(6):e0218618.
    View on PubMed
  4. Greenland NY, Zhang L, Cowan JE, Carroll PR, Stohr BA, Simko JP. Correlation of a Commercial Genomic Risk Classifier with Histological Patterns in Prostate Cancer. J Urol. 2019 07; 202(1):90-95.
    View on PubMed
  5. Davis JL, Lockwood CM, Stohr B, Boecking C, Al-Ibraheemi A, DuBois SG, Vargas SO, Black JO, Cox MC, Luquette M, Turpin B, Szabo S, Laetsch TW, Albert CM, Parham DM, Hawkins DS, Rudzinski ER. Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal Tumors. Am J Surg Pathol. 2019 Apr; 43(4):435-445.
    View on PubMed
  6. Kyle Brian Zuniga, Samuel L. Washington, Jeffry Simko, Nancy Greenland, Bradley A. Stohr, Janet E. Cowan, Imelda Tenggara, Martina Maggi, June M. Chan, Matthew R. Cooperberg, Peter Carroll. Cribriform pattern, Genomic Prostate Score, and adverse pathology at radical prostatectomy in a cohort of prostate cancer patients initially on active surveillance. Journal of Clinical Oncology. 2019 Mar 1; 37(7_suppl):88-88.
    View on PubMed
  7. Ravindranathan A, Cimini B, Diolaiti ME, Stohr BA. Preliminary development of an assay for detection of TERT expression, telomere length, and telomere elongation in single cells. PLoS One. 2018; 13(12):e0206525.
    View on PubMed
  8. Leapman MS, Nguyen HG, Cowan JE, Xue L, Stohr B, Simko J, Cooperberg MR, Carroll PR. Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy. Eur Urol. 2018 11; 74(5):668-675.
    View on PubMed
  9. Rudzinski ER, Lockwood CM, Stohr BA, Vargas SO, Sheridan R, Black JO, Rajaram V, Laetsch TW, Davis JL. Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors. Am J Surg Pathol. 2018 07; 42(7):927-935.
    View on PubMed
  10. Sirohi D, Vaske C, Sanborn Z, Smith SC, Don MD, Lindsey KG, Federman S, Vankalakunti M, Koo J, Bose S, Peralta-Venturina M, Ziffle JV, Grenert JP, Miller S, Chiu C, Amin MB, Simko JP, Stohr BA, Luthringer DJ. Polyoma virus-associated carcinomas of the urologic tract: a clinicopathologic and molecular study. Mod Pathol. 2018 09; 31(9):1429-1441.
    View on PubMed
  11. Michael Leapman, Hao Nguyen, Janet Cowan, Lingru Xue, Bradley Stohr, Jeffry Simko, Matthew Cooperberg, Peter Carroll. PD56-12 COMPARISON OF A LOW-COST IMMUNOHISTOCHEMISTRY MARKER PANEL WITH A CELL-CYCLE PROGRESSION ASSAY FOR THE PREDICTION OF OUTCOME AFTER RADICAL PROSTATECTOMY. The Journal of Urology. 2018 Apr 1; 199(4):e1066.
    View on PubMed
  12. Michael Leapman, Hao Gia Nguyen, Janet E. Cowan, Lingru Xue, Bradley Stohr, Jeffry Simko, Matthew R. Cooperberg, Peter Carroll. Comparison of a low-cost immunohistochemistry marker panel with a cell-cycle progression assay for the prediction of outcome after radical prostatectomy. Journal of Clinical Oncology. 2018 Feb 20; 36(6_suppl):118-118.
    View on PubMed
  13. Williamson SR, Grignon DJ, Calió A, Stohr BA, Eble JN, Cheng L. Reply to Chou et al 'Do significant TFE3 gene rearrangements occur in succinate dehydrogenase deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution' Mod Pathol 2017; in press. Mod Pathol. 2017 10; 30(10):1509-1511.
    View on PubMed
  14. Wolfgang Michael Korn, Iwei Yey, Jessica Van Ziffle, James P Grenert, Nancy Joseph, David A. Solomon, Megan Laurance, Eric Talevich, Courtney Onodera, Gregor Krings, Bradley A. Stohr, Amie Blanco, Boris C. Bastian. Targeted next-generation DNA sequencing of paired tumor and normal DNA to reveal frequent actionable germline alterations. Journal of Clinical Oncology. 2017 May 20; 35(15_suppl):11575-11575.
    View on PubMed
  15. Leapman MS, Cowan JE, Simko J, Roberge G, Stohr BA, Carroll PR, Cooperberg MR. Application of a Prognostic Gleason Grade Grouping System to Assess Distant Prostate Cancer Outcomes. Eur Urol. 2017 05; 71(5):750-759.
    View on PubMed
  16. Calió A, Grignon DJ, Stohr BA, Williamson SR, Eble JN, Cheng L. Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation. Mod Pathol. 2017 03; 30(3):407-415.
    View on PubMed
  17. Liu SY, Joseph NM, Ravindranathan A, Stohr BA, Greenland NY, Vohra P, Hosfield E, Yeh I, Talevich E, Onodera C, Van Ziffle JA, Grenert JP, Bastian BC, Chen YY, Krings G. Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity. Mod Pathol. 2016 09; 29(9):1012-27.
    View on PubMed
  18. Vukovic LD, Jevtic P, Zhang Z, Stohr BA, Levy DL. Nuclear size is sensitive to NTF2 protein levels in a manner dependent on Ran binding. J Cell Sci. 2016 Mar 15; 129(6):1115-27.
    View on PubMed
  19. Barfoot T, Herdendorf TJ, Behning BR, Stohr BA, Gao Y, Kreuzer KN, Nelson SW. Functional Analysis of the Bacteriophage T4 Rad50 Homolog (gp46) Coiled-coil Domain. J Biol Chem. 2015 Sep 25; 290(39):23905-15.
    View on PubMed
  20. Frank AK, Tran DC, Qu RW, Stohr BA, Segal DJ, Xu L. The Shelterin TIN2 Subunit Mediates Recruitment of Telomerase to Telomeres. PLoS Genet. 2015 Jul; 11(7):e1005410.
    View on PubMed

Go to UCSF Profiles, powered by CTSI